ABSTRACT
Introduction Hemoglobin A1c (HbA1c) measurement in epidemiology studies could be increased if reliability of measurements in frozen stored samples was known. In the REasons for Geographic and Racial Differences in Stroke, a longitudinal study of 30,239 Black and White U.S. adults, we investigated reliability of HbA1c measurements for two types of samples stored at -80°C for up to 14 years.
Methods Among 917 participants without diabetes, HbA1c was measured in 2017 in frozen packed cells from the first visit (2003-07) and in frozen whole blood samples from the second visit (2013-16). To study reliability, associations between HbA1c and glycemia-related characteristics were examined.
Results Each 10mg/dL greater fasting glucose was associated with 0.08% (95%CI: 0.05-0.11%) greater HbA1c in frozen packed cells (visit 1) and 0.10% (95%CI: 0.08-0.12%) greater HbA1c in whole blood (visit 2). HbA1c was also similarly higher with both methods with increasing age, gender, systolic blood pressure, body mass index, high-density lipoprotein, triglycerides, C-reactive protein, and hemoglobin. Using both methods, ≤3.5% were classified with diabetes based on HbA1c ≥6.5%.
Conclusions In REGARDS participants without diabetes, HbA1c measurement appeared reliable in frozen packed cells or whole blood under long-term storage, suggesting acceptability for study of the epidemiology of HbA1c.
Competing Interest Statement
Debora Kamin Mukaz, PhD, MS has no conflict of interest to declare. Stephanie Tison, DrPH has no conflict of interest to declare. D. Leann Long, PhD received investigator-initiated research support from Amgen, Inc. for work unrelated to this manuscript. April P. Carson, PhD, MSPH previously received investigator-initiated funding from Amgen, Inc. for work unrelated work to this manuscript. Kelly J. Hunt, PhD has no conflict of interest to declare. Suzanne E. Judd, PhD, MPH has no conflict of interest to declare. Mary Cushman, MD, MSc has no conflict of interest to declare.
Funding Statement
ACKNOWLEDGMENT This research project is supported by cooperative agreement U01 NS041588 co-funded by the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Aging (NIA), National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIA. Representatives of the NINDS were involved in the review of the manuscript but were not directly involved in the collection, management, analysis or interpretation of the data. Additional support was from the NIH National Institute of General Medical Sciences P20GM135007 and the NIH Office of the Director UG3OD023316. The authors thank the other investigators, the staff, and the participants of the REGARDS study for their valuable contributions. A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org. DISCLAIMER This article was prepared while Stephanie Tison was employed at the University of Alabama at Birmingham as a Graduate Research Assistant for the REGARDS research project. The opinions expressed in this article are the author's own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The REasons for Geographic and Racial Differences in Stroke study protocol was reviewed and approved by Institutional Review Boards of participating institutions. Conduct of the pilot study was approved by the University of Vermont Institutional Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data are available from the University of Alabama at Birmingham. Requests to access these datasets should be directed to regardsadmin{at}uab.edu.
